首页|艾司氯胺酮的临床应用进展

艾司氯胺酮的临床应用进展

扫码查看
艾司氯胺酮是氯胺酮的纯右旋同分异构体,与谷氨酸N-甲基-D-天冬氨酸受体和μ阿片受体亲和力更高,具有更强的镇静、镇痛、抗抑郁等作用,并且起效和消除迅速,抑制呼吸作用弱,可轻微兴奋循环系统,可扩张气管及支气管,不良反应发生率低,在精神疾病领域和临床麻醉应用广泛.本文对其临床应用及不良反应进行综述,以期为艾司氯胺酮在医疗使用中提供借鉴和参考.
Advance of esketamine in clinical application
Esketamine is the pure enantiomer of racemic ketamine,with higher affinity for N-methyl-D-aspartate(NMDA)receptors and p-opioid receptors.It possesses stronger sedative,analgesic,and antidepressant effects,with rapid onset and elimination.It has a weak respiratory depressive effect and can mildly stimulate the cardiovascular system.It can also dilate the bronchi and bronchioles.Esketamine has a low incidence of adverse reactions and is widely used in the field of mental illness and clinical anesthesia.This article provides a comprehensive review of its clinical applications and adverse reactions,aiming to provide references and guidance for the medical use of esketamine.

esketamineclinical applicationanesthesiaantidepressantpostoperative cognitive dysfunction

田春林、涂青梅、陈好亮、田刚

展开 >

443000 湖北省宜昌市,三峡大学附属仁和医院

湖北医药学院附属太和医院

湖北医药学院附属人民医院

艾司氯胺酮 临床应用 麻醉 抗抑郁 术后认知功能障碍

湖北省自然科学基金

2014CFC1150

2024

河北医药
河北省医学情报研究所

河北医药

CSTPCD
影响因子:1.075
ISSN:1002-7386
年,卷(期):2024.46(8)
  • 35